ALAFY fundamentals
Key facts
Market capitalization78.33 MEUR
Basic EPS (TTM)−0.38EUR
Founded2012
CEONicolas Sordet
Websiteafyren.com
About
Afyren SAS engages in the development of microbiology and bioprocess engineering from non-food biomass. Its products include the following bio-sourced acids: acetic, propionic, butyric, isobutyric, valeric, isovaleric, and caproic. The company was founded by Régis Nouaille and Jérémy Pessiot on April 11, 2012 and is headquartered in Clermont-Ferrand, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−410%
−370%
−330%
−290%
−250%
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−6.00 M
−4.00 M
−2.00 M
0.00
2.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
No dividends
ALAFY has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company